Fascinating talk by Boro Dropulic from Caring Cross on plans to improve affordability and access to CAR T-cell therapy. I liked production at the point of care, a companion facility on site to engineer the T-cells. Good work on mitigating antigen loss and improving persistence.

Early intervention and prevention of type II diabetes using AI www.theguardian.com/society/2024...

Interesting to see virtual cells back in the news. The full realisation of this epic ambition is of course someway off, however it's going to be a driver for AI applied to omics data. Good to see #openscience highlighted #AIVC #stanford #CZI #genetech www.cell.com/cell/fulltex...

Very happy to be here on #bluesky after making a break from other increasingly politically skewed platforms.